Bioequivalence Study of Flibanserin From AphroFemine 100 mg F.C.T (Bio Med for Pharmaceuticals Industries (BIOMED), Egypt) Versus Addyi 100 mg Tablets (Sprout Pharmaceuticals, Inc., USA)

计划入组 26 人 · 首次发布于 2020 年 7 月 31 日

Cholesterol-lowering Effects of Lupin Protein

计划入组 66 人 · 首次发布于 2011 年 2 月 28 日

To Demonstrate the Relative Bioavailability of Alprazolam Tablets, 2 mg

计划入组 26 人 · 首次发布于 2009 年 6 月 3 日

Filgrastim biosimilar (Lupin)

ARAC

Denosumab biosimilar (Lupin)

LUPIN PHARMACEUTICALS, INC.

United States

LUPIN PHARMACEUTICALS

India

Lupin, Inc.

United States

Catalyst Pharmaceuticals Secures Patent Protection for FIRDAPSE Until 2035 Through Lupin Settlement

Lupin Settles $90 Million Patent Dispute with Astellas to Secure Mirabegron Market Access

FDA Approves 25 First-Time Generic Drugs in First Half of 2025, Expanding Access to Critical Therapies